These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 36270580)

  • 21. α-Synuclein aggregation at low concentrations.
    Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA
    Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):701-709. PubMed ID: 31096048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial Mutations and Post-translational Modifications of UCH-L1 in Parkinson's Disease and Neurodegenerative Disorders.
    Lee YC; Hsu SD
    Curr Protein Pept Sci; 2017; 18(7):733-745. PubMed ID: 26899237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Vitro Analysis of α-Synuclein Amyloid Formation and Cross-Reactivity.
    Horvath I; Rocha S; Wittung-Stafshede P
    Methods Mol Biol; 2018; 1779():73-83. PubMed ID: 29886528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinolinic Acid Amyloid-like Fibrillar Assemblies Seed α-Synuclein Aggregation.
    Tavassoly O; Sade D; Bera S; Shaham-Niv S; Vocadlo DJ; Gazit E
    J Mol Biol; 2018 Oct; 430(20):3847-3862. PubMed ID: 30098337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structures and free energy landscapes of the A53T mutant-type α-synuclein protein and impact of A53T mutation on the structures of the wild-type α-synuclein protein with dynamics.
    Coskuner O; Wise-Scira O
    ACS Chem Neurosci; 2013 Jul; 4(7):1101-13. PubMed ID: 23607785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-Turn exchanges in the α-synuclein segment 44-TKEG-47 reveal high sequence fidelity requirements of amyloid fibril elongation.
    Agerschou ED; Schützmann MP; Reppert N; Wördehoff MM; Shaykhalishahi H; Buell AK; Hoyer W
    Biophys Chem; 2021 Feb; 269():106519. PubMed ID: 33333378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis of the interplay between α-synuclein and Tau in regulating pathological amyloid aggregation.
    Lu J; Zhang S; Ma X; Jia C; Liu Z; Huang C; Liu C; Li D
    J Biol Chem; 2020 May; 295(21):7470-7480. PubMed ID: 32291284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temperature is a key determinant of alpha- and beta-synuclein membrane interactions in neurons.
    Ramalingam N; Dettmer U
    J Biol Chem; 2021; 296():100271. PubMed ID: 33428933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils.
    Dhakal S; Wyant CE; George HE; Morgan SE; Rangachari V
    J Mol Biol; 2021 May; 433(10):166953. PubMed ID: 33771571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the Roles of Post-Translational Modifications in the Pathogenesis of Parkinson's Disease Using Synthetic and Semisynthetic Modified α-Synuclein.
    Chen H; Zhao YF; Chen YX; Li YM
    ACS Chem Neurosci; 2019 Feb; 10(2):910-921. PubMed ID: 30628768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Terminal Acetylation of α-Synuclein Slows down Its Aggregation Process and Alters the Morphology of the Resulting Aggregates.
    Bell R; Thrush RJ; Castellana-Cruz M; Oeller M; Staats R; Nene A; Flagmeier P; Xu CK; Satapathy S; Galvagnion C; Wilson MR; Dobson CM; Kumita JR; Vendruscolo M
    Biochemistry; 2022 Sep; 61(17):1743-1756. PubMed ID: 35944093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA; Harper JD; Lansbury PT
    Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice.
    Rutherford NJ; Dhillon JS; Riffe CJ; Howard JK; Brooks M; Giasson BI
    Hum Mol Genet; 2017 Dec; 26(24):4906-4915. PubMed ID: 29036344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation.
    Anderson VL; Ramlall TF; Rospigliosi CC; Webb WW; Eliezer D
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18850-5. PubMed ID: 20947801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ; Choi MY; Im H
    Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of N-terminal Acetylation on the Aggregation of Disease-related α-synuclein Variants.
    Bell R; Castellana-Cruz M; Nene A; Thrush RJ; Xu CK; Kumita JR; Vendruscolo M
    J Mol Biol; 2023 Jan; 435(1):167825. PubMed ID: 36099961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A triple-emission fluorescent probe reveals distinctive amyloid fibrillar polymorphism of wild-type alpha-synuclein and its familial Parkinson's disease mutants.
    Celej MS; Caarls W; Demchenko AP; Jovin TM
    Biochemistry; 2009 Aug; 48(31):7465-72. PubMed ID: 19586054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
    Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
    Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fundamental mechanisms of amyloid fibril formation by alpha-synuclein in Parkinson's disease: quantitative modelling].
    Galvagnion C; Buell AK
    Med Sci (Paris); 2015; 31(6-7):597-600. PubMed ID: 26152159
    [No Abstract]   [Full Text] [Related]  

  • 40. Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration.
    Ziaunys M; Sakalauskas A; Mikalauskaite K; Smirnovas V
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.